WO2005041941A3 - Valsartan containing formulation - Google Patents
Valsartan containing formulation Download PDFInfo
- Publication number
- WO2005041941A3 WO2005041941A3 PCT/CZ2004/000073 CZ2004000073W WO2005041941A3 WO 2005041941 A3 WO2005041941 A3 WO 2005041941A3 CZ 2004000073 W CZ2004000073 W CZ 2004000073W WO 2005041941 A3 WO2005041941 A3 WO 2005041941A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- valsartan
- containing formulation
- valsartan containing
- formulation
- weight
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA200500973A EA008063B1 (en) | 2003-11-03 | 2004-11-02 | Valsartan containing formulation |
EP04797393A EP1680095A2 (en) | 2003-11-03 | 2004-11-02 | Valsartan containing formulation |
SK5047-2005A SK50472005A3 (en) | 2003-11-03 | 2004-11-02 | Tablet containing valsartan prepared via direct tabletting |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZPV2003-2984 | 2003-11-03 | ||
CZ20032984A CZ294505B6 (en) | 2003-11-03 | 2003-11-03 | Tablet containing valsartan and prepared by direct tabletting |
CZPV2004-1020 | 2004-10-07 | ||
CZ20041020A CZ297417B6 (en) | 2004-10-07 | 2004-10-07 | Valsartan containing pharmaceutical composition |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005041941A2 WO2005041941A2 (en) | 2005-05-12 |
WO2005041941A3 true WO2005041941A3 (en) | 2006-04-20 |
Family
ID=34553093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CZ2004/000073 WO2005041941A2 (en) | 2003-11-03 | 2004-11-02 | Valsartan containing formulation |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1680095A2 (en) |
EA (1) | EA008063B1 (en) |
PL (1) | PL382044A1 (en) |
SK (1) | SK50472005A3 (en) |
WO (1) | WO2005041941A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR200703568A1 (en) | 2007-05-24 | 2008-07-21 | Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� | Valsartan formulations |
DE102008047910A1 (en) | 2008-09-19 | 2010-03-25 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Tabletting excipient based on lactose and cellulose |
EP2405899A2 (en) | 2009-03-11 | 2012-01-18 | Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi | Valsartan formulations |
DE102011108762A1 (en) * | 2011-07-28 | 2013-01-31 | Stada Arzneimittel Ag | A compressed solid pharmaceutical composition comprising amorphous particulate valsartan as an active ingredient |
EP4295839A1 (en) | 2022-06-20 | 2023-12-27 | KRKA, d.d., Novo mesto | Combination of valsartan and indapamide |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997049394A2 (en) * | 1996-06-27 | 1997-12-31 | Novartis Ag | Sold oral dosage forms of valsartan |
WO2000038676A1 (en) * | 1998-12-23 | 2000-07-06 | Novartis Ag | Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors |
-
2004
- 2004-11-02 PL PL382044A patent/PL382044A1/en not_active Application Discontinuation
- 2004-11-02 WO PCT/CZ2004/000073 patent/WO2005041941A2/en active Search and Examination
- 2004-11-02 EP EP04797393A patent/EP1680095A2/en not_active Withdrawn
- 2004-11-02 EA EA200500973A patent/EA008063B1/en not_active IP Right Cessation
- 2004-11-02 SK SK5047-2005A patent/SK50472005A3/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997049394A2 (en) * | 1996-06-27 | 1997-12-31 | Novartis Ag | Sold oral dosage forms of valsartan |
WO2000038676A1 (en) * | 1998-12-23 | 2000-07-06 | Novartis Ag | Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors |
Non-Patent Citations (1)
Title |
---|
SCHMIDT PC, CHRISTIN I: "Wirk- und Hilfsstoffe für Rezeptur, Defektur und Grossherstellung", 1999, WISSENSCHAFTLICHE VERLAGSGESELLSCHAFT MBH, STUTTGART, XP002336328 * |
Also Published As
Publication number | Publication date |
---|---|
EP1680095A2 (en) | 2006-07-19 |
PL382044A1 (en) | 2007-08-06 |
WO2005041941A2 (en) | 2005-05-12 |
SK50472005A3 (en) | 2005-09-08 |
EA008063B1 (en) | 2007-02-27 |
EA200500973A1 (en) | 2006-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200608029B (en) | Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs | |
AU2003285193A1 (en) | Aluminum phosphate compounds, compositions, materials and related composites. | |
AU2003246810A1 (en) | Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives | |
IL219671A0 (en) | 1,2- benzoxazoles and use thereof in the preparation of a medicament | |
AU2003299826A1 (en) | Pharmaceutical safety dosage forms | |
WO2006127053A3 (en) | Controlled release oral delivery systems | |
IL220759A (en) | 3,5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo [4,5-d] pyrimidin-2-one compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments | |
WO2006008614A3 (en) | A synergistic insecticidal composition containing chloronicotynyle and pyrethroids compounds | |
IL176005A0 (en) | 2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same | |
WO2006056696A3 (en) | 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof | |
AU2003301410A1 (en) | Polymeric materials for site specific delivery to the body | |
EP2497513B8 (en) | Inhalator for powdery, in particular medical, substances | |
AU2002354054A1 (en) | Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient | |
WO2005067887A3 (en) | Formulations of ramipril | |
WO2005084648A8 (en) | Pharmaceutical compositions comprising candesartan cilexetil | |
WO2011110854A3 (en) | The use of amisulpride as an anti-emetic | |
HK1129111A1 (en) | Tiotropium salts, pharmaceutical formulations containing the salts and the use thereof | |
AU2003231352A1 (en) | Biocidal formulation and methods for the preparation thereof | |
WO2008056375A3 (en) | Pharmaceutical formulations comprising valsartan | |
PL394600A1 (en) | Vinylazocycloalkanyl compound, process for the preparation thereof, its use and pharmaceutical composition | |
AU2003205717A1 (en) | New medicinal compositions containing heterocyclical compounds in addition to anticholinergics | |
IL181216A (en) | 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same | |
WO2005041941A3 (en) | Valsartan containing formulation | |
AU2003272903A1 (en) | Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same | |
AU2003267602A1 (en) | Polymer compositions for administration to animals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref document number: 50472005 Country of ref document: SK Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 382044 Country of ref document: PL |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 200500973 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004797393 Country of ref document: EP |
|
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWP | Wipo information: published in national office |
Ref document number: 2004797393 Country of ref document: EP |